A trial funded by AstraZeneca found the drug is effective in stopping cancer cells from using hormones to grow Events
Charities and campaigners said the new findings add to the 'betrayal' that they cannot get the life-extending drug on the NHS in England when it is available in Scotland. Events
It is the first worldwide study to show that using blood tests to find early signs of cancer resistance to treatment helps patients Events
A trial called Serena-6 shows that camizestrant stops cancer cells from using hormones to grow. Events
Experts praise groundbreaking results from therapy using genetically modified Car T-cells Cancer patients treated with a pioneering immunotherapy that genetically modifies their own cells to wipe out tumours live 40% longer, according to “exciting” and “groundbreaking” results from a world-first clinical trial.Car T-cell therapy is a new form of immunotherapy where a patient’s own T-cells – a type of white blood cell – are tweaked in a lab to target and kill cancer cells. The designer cells are then infused back into their bloodstream to fight the disease. Continue reading... Science
Thousands of women could benefit after tests showed the method was more effective than the current NHS offering. Events